@article{966c79d40f6741b8b501f419d09abbdd,
title = "Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting",
keywords = "PSCK9 inhibitor, atherosclerosis, bempedoic acid, coronary artery bypass grafting, coronary artery disease, ezetimibe, inclisiran, statin intolerance, statin-associated muscle symptoms, Anticholesteremic Agents, Humans, Cholesterol, LDL, Hypercholesterolemia, Coronary Artery Bypass/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors",
author = "Deo, {Salil V.} and Sadeer Al-Kindi and Virani, {Salim S.} and Stephen Fremes",
year = "2024",
month = feb,
doi = "10.1016/j.jtcvs.2023.05.028",
language = "English (US)",
volume = "167",
pages = "723--730.e4",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "2",
}